… Get the latest Ovid Therapeutics (OVID) stock price quote with real-time news, financials, charts and other important investing information. The best long-term & short-term Ovid Therapeutics share price prognosis for 2021, 2022, 2023, 2024, 2025, … Ovid … The lighter blue line represents the stock's consensus price target. To see all exchange delays and terms of use please see disclaimer. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Copyright © 2021. Ovid Therapeutics Inc. (OVID) stock forecast and price target. ", Start Your Risk-Free Trial Subscription Here, Perion Networks Stock Has More Upside From Here, Closing prices for crude oil, gold and other commodities, UK top court gives Uber drivers benefits in landmark ruling, Water leaks indicate new damage at Fukushima nuclear plant, Massive breach fuels calls for US action on cybersecurity, 'Mom, can I buy stocks?' Ovid Therapeutics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and … What this means: InvestorsObserver gives Ovid Therapeutics Inc (OVID) an overall rank of 37, which is below average. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The price target was set to $17.00 → $5.00. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 ----- Michael Higgins, an analyst with Ladenburg Thalmann, reiterated a buy rating on Ovid's stock … Learn more. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Try POWR Ratings for free. Learn more. Analysts have given the company’s stock an average 52-week price target of $8, forecast … Ovid Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock… All 'A' Rated Buy Stocks, • How to Ride the 2021 Stock Market Bubble, • Stay Away From These 3 Overvalued EV Stocks, • This Stock of the Week has a Berry on Top. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Ovid Therapeutics Stock Forecast, OVID stock price prediction. Teachable moments from GameStop, Deere & Company (NYSE:DE) Turns In Huge Earnings Beat, Jack In The Box Stock Is Ready To Spring Forward. $6.00. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The high price target for OVID is $40.00 and the low price target for OVID is $4.00. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Last 30 Days The market is probably reacting to Ovid getting a buy rating from an analyst. investment rating Login Just enter your email address below. OVID has a higher upside potential (average analyst target price relative to current price) than 85.78% of all US stocks. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. View our full suite of financial calendars and market data tables, all for free. Just click the link Analyst Price Target on OVID. Join. OVID 3.73 0.31 (9.06%). Fundamental company data provided by Zacks Investment Research. You can unlock it all now. According to . The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors. Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Ovid Therapeutics Inc's variance in analysts' estimates is lower than 14.53% of stocks … (79.64% Upside) Based on 6 analysts offering 12 month price targets for Ovid Therapeutics in the last 3 months. OVID: Get the latest Ovid Therapeutics stock price and detailed information including OVID news, historical charts and realtime prices. Use the tables below to see what analysts covering Ovid Therapeutics Inc think about its future price and what recommendations they have for investors and traders. Individual investors are positioning for triple and quadruple-digit gains by buying this sub-$1 stock that has the drills turning on a massive discovery. Further, Ovid Therapeutics Inc. (OVID) has a beta value of 1.83, and an average true range (ATR) of 0.3. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Looking for new stock ideas? See what's happening in the market right now with MarketBeat's real-time news feed. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Arctic Animals Preschool Art, María Teresa Zambada Niebla Instagram, Colman's Dry Mustard Powder 16 Oz, Where To Watch Clifford The Big Red Dog, Omaka Aviation Heritage Centre Prices,